# Epicardial adipose tissue volume is associated with impaired left atrial mechanics in hypertensive overweight/obese patients: the potential mediating role of insulin resistance

**Authors:** Shuang Yin, Xu Zhao, Qing Liu, Tingting Fu, Qiaobing Sun, Yu Pan, Mengxuan Wang, Bing Wang, Minghui Gong, Yan Lu, Chongfu Jia, Yinong Jiang, Yan Liu

PMC · DOI: 10.3389/fnut.2026.1778193 · Frontiers in Nutrition · 2026-02-23

## TL;DR

Excess heart fat is linked to worse heart function in overweight/obese people with high blood pressure, possibly due to insulin resistance.

## Contribution

Shows that epicardial fat independently affects left atrial mechanics, partially mediated by insulin resistance in hypertensive patients.

## Key findings

- Higher EAT volume correlates with reduced LA strain and increased stiffness in overweight/obese hypertensive patients.
- TyG-BMI explains part of the relationship between EAT volume and impaired LA mechanics.
- EAT volume remains a significant predictor of LA dysfunction after adjusting for other factors.

## Abstract

Epicardial adipose tissue (EAT) is implicated in cardiovascular disease, but its specific impact on left atrial (LA) mechanics in hypertensive overweight/obese patients remains unclear. We investigated the association between EAT volume (EATV) and LA dysfunction in this high-risk population.

In this cross-sectional study, 264 hypertensive overweight/obese patients (body mass index ≥24 kg/m2) underwent coronary computed tomography angiography (CCTA) for EATV quantification. Participants were stratified into low- and high-EATV groups by the median value (72.67 cm3). LA strain analysis, including reservoir strain (LAs-s), conduit strain (LAs-e), booster strain (LAs-a), and LA stiffness index (LASI), were assessed by two-dimensional speckle tracking echocardiography. The triglyceride glucose-body mass index (TyG-BMI) was calculated to reflect the insulin resistance. Multivariable regression and mediation analyses evaluated associations between EATV and LA mechanics.

The high-EATV group had significantly higher TyG-BMI and longer hypertension duration. Despite comparable conventional echocardiographic parameters, this group demonstrated impaired LA mechanics, evidenced by reduced LAs-s, LAs-e, and LAs-a, alongside elevated LASI. EATV was inversely correlated with LA strains (LAs-s, LAs-e, LAs-a) but positively correlated with both TyG-BMI and LASI. After multivariable adjustment, EATV remained independently associated with LAs-s, LAs-a, and LASI. Mediation analysis indicated that TyG-BMI explained 12.87% of the association between EATV and LAs-s, and 10.00% of the association between EATV and LASI.

Increased EATV is independently associated with impaired LA mechanics in hypertensive overweight/obese patients. Insulin resistance, assessed by TyG-BMI, may partly explain these associations, linking epicardial adiposity to early atrial dysfunction.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, ANGPTL2 (angiopoietin like 2) [NCBI Gene 23452] {aka ARP2, HARP}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}
- **Diseases:** systole (MESH:D000092244), coronary stenosis (MESH:D023921), HFpEF (MESH:D054144), visceral adiposity (MESH:D007418), LA (MESH:D059446), metabolic dysfunction (MESH:D008659), hypotension (MESH:D007022), atrial mechanical abnormalities (MESH:D041781), atrial myopathy (MESH:D009135), atrial cardiomyopathy (MESH:D009202), cardiac dysfunction (MESH:D006331), Overweight (MESH:D050177), coronary artery disease (MESH:D003324), obstructive sleep apnea-hypopnea syndrome (MESH:D020181), LA dysfunction (MESH:D018487), EAT (MESH:D018205), Obesity (MESH:D009765), HF (MESH:D006333), essential hypertension (MESH:D000075222), weight-loss (MESH:D015431), angina pectoris (MESH:D000787), IR (MESH:D007333), atrial dysfunction (MESH:C538261), Chronic Kidney Disease (MESH:D051436), CVD (MESH:D002318), myocardial infarction (MESH:D009203), malignancies (MESH:D009369), ischemic stroke (MESH:D002544), valvular disease (MESH:D006349), AF (MESH:D001281), DM (MESH:D003920), death (MESH:D003643), atrial impairment (MESH:D064752), Hypertension (MESH:D006973), CHD (MESH:D003327), adipose inflammation (MESH:D007249), hepatic or renal dysfunction (MESH:D008107), thrombotic (MESH:D013927), fibrosis (MESH:D005355)
- **Chemicals:** cholesterol (MESH:D002784), creatinine (MESH:D003404), glucose (MESH:D005947), calcium (MESH:D002118), metoprolol (MESH:D008790), lipid (MESH:D008055), triglyceride (MESH:D014280), nitroglycerin (MESH:D005996), uric acid (MESH:D014527), TG (MESH:D013866), TC (MESH:D013667), ACEI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968267/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968267/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968267/full.md

---
Source: https://tomesphere.com/paper/PMC12968267